13
2010-08The Ministry of Health considers HFMD drug and vaccine R&D a top public health priority. Our cooperation with IPS will allow a comprehensive analysis of what leads to severe disease and death in infected children. The study is open to other clinical research centers in China and the Asian region....Institut Pasteur of Shanghai (IPS), a member institute of the Chinese Academy of Sciences, announces today the signing of a clinical research agreement with the Children’s Hospital of Fudan University (CHFU) on hand foot mouth disease (HFMD), China’s second most lethal infectious disease in 201...
08
2010-07Mrs. Valérie Pécresse, French Minister of Higher Education and Research visited Institut Pasteur of Shanghai (IPS) on July 6.
On a brief introduction of IPS, Prof. SUN Bing, Co-Director presented IPS’s mission, research focuses and achievements. IPS conducts basic research in combining vir...
22
2010-06Institut Pasteur Shanghai today signed a partnership agreement with the Griffith University’s Institute for Glycomics.
The pair will strengthen collaborative drug research and development between Australia and China, positioning themselves as leaders in drug discovery and consolidate their r...
20
2010-05As an example of team spirit of IPS,he introduced the creation of a task force at IPS to fight against Hand Foot and Mouth Disease which has infected nearly half a million and killed 260 children in China this year.
Altmeyer stressed that in light of the growing importance of China in the scienti...On May 11, Mrs. Roselyne Bachelot, French Minister of Health and Sports visited Institut Pasteur of Shanghai (IPS), together with Mr. Hervé Ladsous, Ambassador of France in China and Mr. Thierry Mathou, General Consulate of France in Shanghai.
On a brief introduction of IPS, Prof. Ralf Altme...